StonvexLoading…
StonvexStonvexStonvexCore line items from VHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $560.10M | $2.08B | $1.58B | $1.08B |
Operating Income | $32.90M | $63.30M | $94.20M | $85.60M |
Net Income | $2.00M | $-57.60M | $-4.40M | $17.80M |
EPS (Diluted) | $0.07 | $-2.02 | $-0.15 | $0.62 |
Total Assets | $2.61B | $2.63B | $2.72B | $2.76B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $193.70M | $214.00M | $183.50M | $188.50M |
Free Cash Flow OCF − CapEx | $-56.70M | $-82.10M | $-171.90M | $-159.60M |
Shares Outstanding | 28.50M | 29.60M | 28.50M | 28.50M |